I’m a doctor — female nonsmokers get lung cancer more than men, look out for these troubling signs
November is Lung Cancer Awareness Month — an estimated 235,000 new cases of lung cancer and 125,000 deaths are expected to ...
emjreviews.com7h
Lung Cancer Screening Benefits Limited for Smokers with Severe Airflow Limitation
A RECENT study examining the impact of airflow limitation (AL) on lung cancer (LC) screening outcomes suggests that the ...
MRK: Sac-TMT Gets FDA Breakthrough Therapy Designation For EGFR-mutated Advanced Or Metastatic NSCLC
Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...
News Medical on MSN16h
New algorithm identifies tumor cells driving aggressive cancer growth
The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed by Cancer Research UK-funded scientists from UCL and The Francis Crick ...
Cure Today1d
Tiragolumab Plus Tecentriq Misses Survival Endpoint for Lung Cancer Subset
The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...
BioPharma Dive8d
Roche’s TIGIT-targeting drug for cancer fails its biggest test
Long-awaited results released Tuesday showed adding tiragolumab to Roche's immunotherapy Tecentriq did not extend survival in ...
Community Impact Newspaper1d
2 UT Health SA scientists awarded grants for innovative cancer research
In recognition of their innovative cancer research, two scientists at the University of Texas Health Science Center at San ...
Cure Today12d
Magrolimab-Chemo Combo Improves Responses in Metastatic NSCLC
Patients with metastatic non-small cell lung cancer and high CD47 expression showed improved responses to treatment with magrolimab plus docetaxel. Improved outcomes were seen with magrolimab plus ...